Black licorice compound shows promise against inflammatory bowel disease

Researchers have developed a stem cell-based model of the human intestine that may transform how new IBD treatments are discovered. After testing thousands of compounds, they identified glycyrrhizin — a natural substance found in black licorice — as a promising anti-inflammatory candidate. In both lab-grown tissue and mice, the compound reduced intestinal damage and cell death linked to IBD.


http://dlvr.it/TSfWYB

ChatGPT Confesses to a Crime It Didn’t Commit

And that it wasn't even capable of committing.


http://dlvr.it/TSf4FM

The Economic Advantage of On-Premise eDiscovery: Driving Cost Control, Predictability, and Profitability with CloudNine Review

In today’s eDiscovery landscape, organizations face mounting pressure to manage expanding data volumes because of the need to mitigate the growing hosting costs. While cloud-based solutions offer convenience and flexibility, they also introduce ongoing consumption-based hosting costs . . .


The post The Economic Advantage of On-Premise eDiscovery: Driving Cost Control, Predictability, and Profitability with CloudNine Review appeared first on CloudNine.
    

Related Stories



* Accelerating eDiscovery Workflows with CloudNine’s Processing as a Service
* The 2026 C2C Cellebrite User Summit Key Takeaways
* CloudNine’s Next Evolution: Advancing eDiscovery with Automation, Modern Data, and On-Premise Innovation – Part 4 of 4


 


http://dlvr.it/TSdyT7

Scientists discover strange link between vitamin D and pain

Low vitamin D levels could be quietly making breast cancer surgery recovery far more painful. In a new study, patients deficient in vitamin D were three times more likely to experience moderate to severe pain after mastectomy surgery and ended up using significantly more opioid medication to cope. Researchers say vitamin D may help regulate how the body processes pain through its effects on inflammation and the immune system.


http://dlvr.it/TSdbPh

Scientists found a hidden Alzheimer’s trigger and shut it down

A newly identified enzyme called IDOL could become a major new target in the fight against Alzheimer’s disease. Researchers found that removing it from neurons sharply reduced amyloid plaques and improved key brain processes linked to resilience and communication between cells. The discovery may lead to future treatments that go beyond slowing Alzheimer’s — potentially helping protect the brain from further decline.


http://dlvr.it/TSdZ5B